DHR Health and DHR Health Institute for Research and Development have arranged partnerships with other hospitals in this region of southern Texas to establish a protocol to treat COVID-19 patients using donated plasma from those who recovered from the COVID-19 infection. With a large Hispanic population, this effort dovetails with The U.S. Food and Drug Administration (FDA), who has encouraged recovered COVID-19 patients to donate plasma for use in expanded access protocols as well as ongoing clinical trials due to the severe COVID-19 pandemic. Donors will receive a financial stipend as in addition to offering expanded use access DHR Health Institute for Research and Development is conducting clinical trials.
Social Determinants of Health & The Deadly COVID-19 Pathogen
TrialSite News reported that COVID-19 is killing Blacks in America at a horrific rate. Hispanic (Latino) death rates appear higher as well. Reports out of the Western States—where Hispanics frequently represent the largest minority group—data suggests deaths rates could be higher as well—such as recently reported in Utah.
DHR operates in the McAllen-Edinburg-Mission metro area with a population of abou...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).